Add BrightSurf on Google Email

UNDER EMBARGO: Mount Sinai researchers identify potential new treatment for those who act out their dreams while sleeping

Researchers have identified a novel model and therapy to mitigate the development of REM sleep behavior disorder, which affects over 3 million Americans. Dual orexin receptor antagonists have been shown to significantly reduce dream enactment behaviors, providing a promising new treatment option.

Journal of Pharmaceutical Analysis studies shine the light on advancements in pharmaceutical analytical techniques and overcoming chemoresistance

Researchers have developed new methods to analyze dry-coated drug particles using 3D Raman mapping, which can effectively slow down dissolution rates. Another study introduces a novel technique for detecting complex traditional Chinese medicines, preventing adulteration and counterfeiting.

SourceCactus Communications·JournalJournal of Pharmaceutical Analysis·TypeExperimental study·DateMay 24, 2023

A commonly used tool is suboptimal in predicting osteoporosis fracture risk in younger post-menopausal women

A study of nearly 67,200 postmenopausal women found that the Fracture Risk Assessment Tool (FRAX) was inadequate for identifying osteoporotic fracture risk across racial/ethnic categories. However, the Osteoporosis Self-Assessment Tool (OST) was excellent for detecting osteoporosis within each category.

SourceUniversity of California - Los Angeles Health Sciences·JournalJAMA Internal Medicine·TypeData/statistical analysis·DateMay 22, 2023

Delivering on the promise of personalized breast cancer therapy

A Baylor team created a molecular classifier test to identify patients with HER2-positive breast cancer who may benefit from anti-HER2 therapy alone without chemotherapy. The test accurately predicts the most likely response of a tumor to specific treatment regimens, allowing for personalized de-escalation approaches.

SourceBaylor College of Medicine·JournalClinical Cancer Research·TypeRandomized controlled/clinical trial·DateMay 18, 2023

Infarction growth, penumbral consumption after reperfusion in COVID vaccine-naïve patients

A recent study found that COVID-19 infection can lead to increased infarct growth and ongoing tissue consumption even after successful reperfusion through angiography. This suggests a potentially aggressive clinical course for patients with COVID-19 and large-vessel occlusion acute ischemic stroke.

SourceAmerican Roentgen Ray Society·JournalAmerican Journal of Roentgenology·TypeCase study·DateMay 18, 2023

Alternating estrogen and anti-estrogen therapies is effective in treating metastatic breast cancer

Researchers at Dartmouth Cancer Center found that alternating estrogen stimulation and anti-estrogen therapy is an effective treatment for patients with metastatic or advanced ER+ breast cancer. The POLLY trial showed that 42% of patients experienced tumor stabilization, while no patients discontinued treatment due to side effects.

SourceDartmouth Health·JournalClinical Cancer Research·TypeRandomized controlled/clinical trial·DateMay 15, 2023

Bleeding after image-guided breast biopsies: Discontinuing vs. maintaining antithrombotic therapy

A study of 5302 patients found no significant difference in bleeding events between those temporarily discontinuing and maintaining antithrombotic therapy during image-guided breast biopsies. The findings support the safety of continuing antithrombotic therapy, but counsel patients on bruising risk.

SourceAmerican Roentgen Ray Society·JournalAmerican Journal of Roentgenology·TypeImaging analysis·DateMay 10, 2023

Researchers overcome stem cell delivery barrier, paving the way for regenerative medicine

Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.

SourceXi'an Jiaotong-Liverpool University·JournalNano Letters·TypeExperimental study·DateMay 8, 2023

Neuropathic pain: The underlying mechanism and a potential therapeutic target are revealed in mice

Researchers uncover a pathophysiological mechanism that initiates and sustains neuropathic pain in mice, identifying Tiam1 as a potential therapeutic target. Targeting spinal Tiam1 with antisense oligonucleotides alleviates neuropathic pain hypersensitivity, offering promise for treating chronic pain.

SourceUniversity of Alabama at Birmingham·JournalNeuron·TypeExperimental study·DateMay 4, 2023

Study identifies genetic mutations that contribute to adult epilepsy

Researchers have identified 11 somatic mutations in the RAS/MAPK pathway that contribute to treatment-resistant adult epilepsy, suggesting the potential for repurposed anti-cancer agents as new treatments. This study provides insight into the genetic mechanisms underlying this form of epilepsy and opens up new avenues for targeted ther...

SourceMass General Brigham·JournalJournal of the American Medical Association·TypeCase study·DateMay 1, 2023

Treatment of children with ADHD

A recent study reveals that many children with attention-deficit/hyperactivity disorder (ADHD) are not receiving adequate treatment. The findings highlight the need for improved communication and access to outpatient mental health care for children with ADHD.

SourceJAMA Network·JournalJAMA Network Open·DateApr 28, 2023

In a ‘rapid autopsy’ study, UCLA researchers identify lethal molecular alterations after present-day therapies fail patients with metastatic melanoma

Researchers analyzed genetic changes in organs of recently deceased patients with metastatic cutaneous melanoma to understand how the disease spreads and evolves. They found that cancer cells take advantage of specific organ environments, pointing to the need for distinct treatment approaches.

SourceUniversity of California - Los Angeles Health Sciences·JournalNature Medicine·TypeExperimental study·DateApr 27, 2023

Existing drugs prevent Alzheimer’s disease-related cognitive impairment in mice, new research at the Lewis Katz School of Medicine at Temple University shows

Researchers at Temple University Health System found that carbonic anhydrase inhibitors reduce inflammation, restore cell function and prevent cognitive impairment in mice with amyloid buildup. CAIs also improved cerebrovascular health and enhanced amyloid-clearing capacity.

SourceTemple University Health System·JournalAlzheimer s & Dementia·DateApr 26, 2023

A 21st-century remedy for missed meds

Researchers at Rice University have created a new technology called PULSED that can deliver time-released drugs and vaccines for extended periods. The technology uses high-resolution 3D printing and soft lithography to produce microcylinders made of biodegradable polymers, which can be loaded with drugs and release them over time.

SourceRice University·JournalAdvanced Materials·TypeExperimental study·DateApr 3, 2023

Use of monoclonal antibodies reduces death, hospitalization risk by more than one-third after COVID-19 diagnosis

Researchers found that using monoclonal antibodies within two days of a COVID-19 diagnosis reduced the risk of hospitalization or death by 39% compared to those who did not receive treatment. This finding suggests that early treatment with monoclonal antibodies significantly reduced the severity of COVID-19.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeObservational study·DateApr 3, 2023

New mechanisms and therapeutic possibilities for heart failure uncovered by scientists at the Lewis Katz School of Medicine at Temple University and Johns Hopkins University

Researchers at Temple University and Johns Hopkins University found that brain-derived neurotrophic factor (BDNF) loss underlies post-myocardial infarction heart failure. BDNF levels can be replenished therapeutically, abolishing damage to heart tissue and enabling recovery.

SourceTemple University Health System·JournalCirculation Research·DateMar 30, 2023

Shining light on aging hearts

A study published in Lasers in Surgery and Medicine suggests that light therapy, known as photobiomodulation (PBM), can improve heart function and reduce the thickness of the cardiac wall in middle-aged mice. The research also found improved neuromuscular coordination and a significant survival rate among mice with severe heart disease.

SourceUniversity at Buffalo·JournalLasers in Surgery and Medicine·DateMar 27, 2023

Wilson’s disease: Bacterial agent opens new therapeutic options

A bacterial molecule, ARBM101, has been found to efficiently lower liver copper levels in a rat model, offering a promising new therapeutic option for Wilson's disease. The treatment approach involves weekly applications followed by month-long breaks, significantly shortening the therapy period.

Real-world studies confirm effectiveness of bulevirtide to treat chronic hepatitis D

Three real-world studies published in the Journal of Hepatology and JHEP Reports demonstrate that bulevirtide is well-tolerated and safe for treating chronic hepatitis delta. Long-term suppressive therapy with BLV monotherapy has the potential to reduce viral replication and improve liver function in difficult-to-treat patients.

SourceElsevier·JournalJournal of Hepatology·TypeExperimental study·DateMar 20, 2023